About IPI
The Institute for Protein Innovation (IPI) is a nonprofit protein research institute located on the Harvard Medical School campus. In addition to novel research, we provide scientists access to protein tools, high-quality recombinant antibodies and learning opportunities to empower groundbreaking work and advance biomedical understanding.
Our mission is to accelerate research and improve human health by providing scientists with openly shared protein tools capable of illuminating fundamental biological processes.
For more information, contact us at communications@proteininnovation.org or find our media resources below.
Quick facts
- IPI is a nonprofit 501(c)3 organization located on the Harvard Medical School campus in Boston’s Longwood Medical and Academic Area.
- IPI was founded in 2017 by Timothy Springer, PhD (Harvard Medical School, Boston Children’s Hospital) and Andrew Kruse, PhD (Harvard University).
- Our goal is to build a scalable, sustainable platform that makes high-quality protein tools widely accessible and accelerates discovery across biology.
- IPI produces synthetic recombinant antibodies and protein tools. We distribute our commercial collections through partnering nonprofit repository, Addgene, and make pre-release antibodies available through our CAAP program.
- Thus far, IPI has explored more than 400 protein targets, with particular focus on neuroscience, where reliable and accessible tools to study complex neural systems are limited.
Recent news
IPI in the spotlight
The Wall Street Journal
In Vivo
Contact our communications team
Our communications team is happy to work with journalists to share compelling stories.
If you’re a member of the press or media, get in touch with our team at:
